Indrayani Biotech Ltd. - Research Center
526445 INDRANIB Group (XT) BSE data
Results
Statement
More
Mar ' 23 |
Mar ' 22 |
Mar ' 21 |
Mar ' 20 |
Mar ' 19 |
Equity share capital
34.23 |
34.23 |
34.23 |
3.64 |
3.64 |
Share application money
Preference share capital
Reserves & surplus
7.67 |
-10.05 |
-14.28 |
-3.39 |
-4.30 |
Secured loans
Unsecured loans
Total
86.42 |
40.91 |
35.38 |
44.58 |
-0.01 |
Gross block
23.81 |
15.33 |
15.11 |
17.36 |
- |
Less : revaluation reserve
Less : accumulated depreciation
Net block
23.81 |
15.33 |
15.11 |
17.36 |
- |
Capital work-in-progress
12.72 |
13.22 |
13.72 |
13.59 |
- |
Investments
Current assets, loans & advances
55.79 |
20.70 |
10.83 |
20.50 |
0.01 |
Less : current liabilities & provisions
13.88 |
8.53 |
4.47 |
6.90 |
0.02 |
Total net current assets
41.91 |
12.18 |
6.37 |
13.61 |
-0.01 |
Miscellaneous expenses not written
Total
86.42 |
40.91 |
35.38 |
44.58 |
-0.01 |
Book value of unquoted investments
Market value of quoted investments
Contingent liabilities
Number of equity sharesoutstanding (Lacs)
342.27 |
342.27 |
342.27 |
36.44 |
36.44 |